Needham & Company upgraded NuVasive (NASDAQ: NUVA) from Underperform to Buy with a price target of $71.00.Analyst Mike Matson comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE